<DOC>
	<DOCNO>NCT01549054</DOCNO>
	<brief_summary>This study healthy subject . There two part study . In first part study subject receive single 10mg dose four formulation E550 . Based result Part 1 , optimal formulation select evaluation Part 2 .</brief_summary>
	<brief_title>A Study Healthy Subjects Evaluate Bioavailability 4 Formulations E5501</brief_title>
	<detailed_description />
	<mesh_term>Purpura , Thrombocytopenic</mesh_term>
	<mesh_term>Purpura</mesh_term>
	<mesh_term>Purpura , Thrombocytopenic , Idiopathic</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<criteria>Healthy adult men woman ( age ≥ 18 ≤ 55 year ) Body mass index ≥ 18.0 kg/m2 ≤ 32.0 kg/m2 time screen baseline Treatment Period 1 Platelet count 120 x 109/L 300 x 109/L baseline Treatment Period 1 , 3 , 5 Women child bear potential must agree use highly effective method contraception , estrogenbased hormonal contraceptive , Treatment Phase study . In addition , standard criterion healthy subject use . Evidence clinically significant cardiovascular , hepatic , gastrointestinal , renal , respiratory , endocrine , hematologic , neurologic , psychiatric disease abnormality know history gastrointestinal surgery could impact PK study drug Agents associate thrombotic event ( include oral contraceptive ) must discontinue within 30 day first study drug administration Evidence organ dysfunction clinically significant event illness subject 's medical history , e.g. , history splenectomy . History arterial venous thrombosis , include partial complete thrombosis ( e.g. , stroke , transient ischemic attack , myocardial infarction , deep vein thrombosis , pulmonary embolism ) . Known family history hereditary thrombophilic disorder ( e.g. , Factor V Leiden , antithrombin III deficiency , etc . ) Hemoglobin less low limit normal level . In addition , standard criterion healthy subject use .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>October 2013</verification_date>
</DOC>